Heartfelt with Dr Melissa Walton-Shirley

View all posts »

MASS-PAC Registry

Nov 11, 2008 00:38 EST


Just a short blurb here on the continued issue of stent selection. 

 Though encouraging that this study looked at 67 different propensity matched  variables along with Mortality,myocardial infarction and TVR at 3 years in the subgroup of diabetics, classically the toughest audience of all, and found decreased incidences of all  the primary endpoints with DES vs. BMS, this wasn't the real story.  The real story is that these patients could even be studied at all, and in most places, their data would just be relegated to the patient's medical record and taken deep into some warehouse for  storage. 

Since this is a registry and not a randomized trial, these patients come to us through inherent selection bias.  Someone already determined which patients could safely get a DES and gave it to them.  But of those who passed the necessary screening of obvious bleeding, upcoming surgery, compliance issues, etc. etc. in order to get a DES, this study suggests they will bode well. 

Our hats are off to the State of Massachusetts  for their required reporting of ALL PCI DATA.  We could definitely take a lesson from them, and perhaps we should just all follow their example without having to be made to.

Melissa 








Your comments
MASS-PAC Registry
# 1 of 2
November 12, 2008 09:37 (EST)
Meridith Mitchell

M2S, Inc. has a very robust registry offering that in addition to a clinical pathway for physicians treating AAA and TAA also provides patient outcomes, device performance and physician practice data.  65% of all AAA/TAA procedures in the U.S. are evaluated using M2S providing the largest population of patients available for deeper clinical research.  Registries are available and tragically under utilized which is limiting the improvement of patient care to that small population of physicians with a truly altruistic approach.

 

Meridith 

# 2 of 2
November 12, 2008 12:15 (EST)
Melissa

Thanks Meredith for the information.  We need more registries AND more RCT's.  I hope important discussions and comments such as these will drive change.

Melissa


You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

About Dr Melissa Walton-Shirley
Dr Walton-Shirley performs invasive cardiology, nuclear cardiology, and stress echocardiography in a private practice in Glasgow, KY.

Her chief medical interests are CHF/hypertrophic obstructive cardiomyopathy and the promotion of primary PCI for acute MI. Recently she played a significant role in helping to launch an ambitious pilot study of primary PCI in Kentucky, the Kentucky Primary Angioplasty Pilot Project. She has also participated in the TIMI 19, Duke-HF, NRMI, and CRUSADE trials and is proud to have been an advocate of the first smoke-free initiative in Kentucky (2011). She champions a smoke-free America.

Dr Walton-Shirley received her undergraduate degree at the University of Kentucky and went to medical school and did her residency and fellowship at the University of Louisville. She is married with two daughters. Her interests include singing, writing poetry and songs, fitness, and, of course, theheart.org.